China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis
China is gradually becoming a competitive force and evolving into the world’s fastest growing market for In Vitro Diagnostics (IVD) products. By 2018 Chinese IVD market with Billion US$ is expected to be twice more than from its current market size in 2013. Immunoassay has the highest market share compared to all other segments of In Vitro Diagnostics. Clinical Chemistry is in the 2nd position, but its market share is declining year on year, however its market is growing year on year. Molecular Diagnostics holds the 3rd position and its market share is also rising year on year. Roche holds the highest market share in China In Vitro Diagnostics market.
This is 3rd edition report on In Vitro Diagnostics sector by Renub Research. Report titled “China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis” provides a comprehensive assessment of the fast–evolving, high–growth IVD Market in China. This 77 page report with 34 Figures studies the China IVD market from 4 view points:
1) Market and Forecast
2) Segment Wise Market & Forecast
3) Development Environment & Regulatory Status in China IVD market
4) Company Wise IVD Sales & Forecast
China IVD Market – Application Segment Analysis (2007 – 2018)
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephonic interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
This is 3rd edition report on In Vitro Diagnostics sector by Renub Research. Report titled “China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis” provides a comprehensive assessment of the fast–evolving, high–growth IVD Market in China. This 77 page report with 34 Figures studies the China IVD market from 4 view points:
1) Market and Forecast
2) Segment Wise Market & Forecast
3) Development Environment & Regulatory Status in China IVD market
4) Company Wise IVD Sales & Forecast
China IVD Market – Application Segment Analysis (2007 – 2018)
- Clinical Chemistry Market
- Immunoassay Market
- Hematology Market
- Coagulation Market
- Microbiology Market
- Molecular Testing Market
- Self Monitoring of Blood Glucose (SMBG) Market
- Point of Care Testing (POCT) Market
- Roche Diagnostic
- Sysmex Corporation
- Mindray Medical International Limited
- Shanghai Kehua Bio–Engineering Co. Ltd.
- Others
- Zhejiang Di’an Diagnostics Technology Co., Ltd
- ADICON Clinical Laboratories
- Guangzhou Kingmed Diagnostics Center Co. Ltd.
- Kindstar Global (Privately held)
- BGI–Shenzhen (Privately held)
- OriGene Technologies (Privately held)
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephonic interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
1. EXECUTIVE SUMMARY
2. CHINA IVD MARKET & MARKET SHARE (2007 – 2018)
2.1 China IVD Market (2007 – 2018)
2.2 China IVD Market Share (2007 – 2018)
2.3 China IVD Market Players Share (2010 – 2018)
3. CHINA IVD MARKET BY SEGMENTS (2007 – 2018)
3.1 China Clinical Chemistry Market (2007 – 2018)
3.2 China Immunoassay Market (2007 – 2018)
3.3 China Hematology Market (2007 – 2018)
3.4 China Coagulation Market (2007 – 2018)
3.5 China Microbiology Market (2007 – 2018)
3.6 China Molecular Testing Market (2007 – 2018)
3.7 China Self Monitoring of Blood Glucose (SMBG) Market (2007 – 2018)
3.8 China Point of Care Testing (POCT) Market (2007 – 2018)
4. DEVELOPMENT ENVIRONMENT OF CHINESE IVD INDUSTRY
4.1 State Healthcare Reforms
4.2 State Citizen–Benefiting Policies
4.3 Requirements of Hospital Upgrading
5. PROFILE OF IN–VITRO DIAGNOSTIC REAGENTS REGISTRATION CONTROL
5.1 Regulatory History in China IVD Market
5.2 Regulatory Status in China IVD Market
5.2.1 Blood Screening Reagents — Drug Administration
5.2.2 Varieties of Blood Screening Reagents
5.2.3 Blood Screening Reagent Test
5.2.4 Nucleic Acid Detection Kits for Blood Screening
5.2.5 Radioactive reagents — Drug Administration
5.2.6 Diagnostic Reagents – Medical Devices Management
5.3 Regulatory Trend in China IVD Market
5.3.1 Blood Screening Reagents Belonging
5.3.2 Quality Improvement
5.3.3 Pre–Evaluation of Registration Standards
6. CHINA IVD INDUSTRY DRIVERS
6.1 Government Efforts to Regulate Laboratory testing
6.2 Increasing Number of Private Hospitals & Independent Testing Laboratories
7. CHINA IVD INDUSTRY CHALLENGE
7.1 Lack of Expertise in Advanced Technology in the Local Companies
7.2 Price Pressures Limits the Participation of Multinational IVD Companies in the China IVD Market
7.3 Reimbursement Rates of Different Products are Various in Different Provinces
8. CHINA IVD MARKET – COMPANY WISE SALES ANALYSIS (2010 – 2018)
8.1 Roche Diagnostic – China IVD Sales & Forecast (2010 – 2018)
8.2 Sysmex Corporation – China IVD Sales & Forecast (2010 – 2018)
8.3 Mindray Medical International Limited – China IVD Sales & Forecast (2010 – 2018)
8.4 Shanghai Kehua Bio–Engineering Co. Ltd. – China IVD Sales & Forecast (2010 – 2018)
8.5 Others – China IVD Sales & Forecast (2010 – 2018)
9. PROFILES OF SELECT PRIVATE CLINICAL LABS AND DIAGNOSTIC SERVICES COMPANIES
9.1 Zhejiang Di’an Diagnostics Technology Co., Ltd.
9.1.1 Company Overview
9.1.2 Products and Services Offered by Di’an
9.2 ADICON Clinical Laboratories (Privately held)
9.2.1 Company Overview
9.2.2 Products and Services Offered by ADICON
9.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
9.3.1 Company Overview
9.3.2 Products and Services Offered by Kingmed
9.4 Kindstar Global (Privately held)
9.4.1 Company Overview
9.4.2 Products and Services Offered by Kindstar
9.5 BGI–Shenzhen
9.5.1 Company Overview
9.5.2 BGI’s Innovative Approach
9.6 OriGene Technologies
9.6.1 Company Overview
9.6.2 Products and Services Offered by OriGene
LIST OF FIGURE:
Figure 2–1: China – IVD Market (Million US$), 2007 – 2013
Figure 2–2: China – Forecast for IVD Market (Million US$), 2014 – 2018
Figure 2–3: China – IVD Market Share (Percent), 2007 – 2013
Figure 2–4: China – Forecast for IVD Market Share (Percent), 2014 – 2018
Figure 2–5: China – IVD Market Players Share (Percent), 2010 – 2013
Figure 2–6: China – Forecast for IVD Market Players Share (Percent), 2014 – 2018
Figure 3–1: China – Clinical Chemistry Market (Million US$), 2007 – 2013
Figure 3–2: China – Forecast for Clinical Chemistry Market (Million US$), 2014 – 2018
Figure 3–3: China – Immunoassay Market (Million US$), 2007 – 2013
Figure 3–4: China – Forecast for Immunoassay Market (Million US$), 2014 – 2018
Figure 3–5: China – Hematology Market (Million US$), 2007 – 2013
Figure 3–6: China – Forecast for Hematology Market (Million US$), 2014 – 2018
Figure 3–7: China – Coagulation Market (Million US$), 2007 – 2013
Figure 3–8: China – Forecast for Coagulation Market (Million US$), 2014 – 2018
Figure 3–9: China – Microbiology Market (Million US$), 2007 – 2013
Figure 3–10: China – Forecast for Microbiology Market (Million US$), 2014 – 2018
Figure 3–11: China – Molecular Testing Market (Million US$), 2007 – 2013
Figure 3–12: China – Forecast for Molecular Testing Market (Million US$), 2014 – 2018
Figure 3–13: China – SMBG Market (Million US$), 2007 – 2013
Figure 3–14: China – Forecast for SMBG Market (Million US$), 2014 – 2018
Figure 3–15: China – POCT Market (Million US$), 2007 – 2013
Figure 3–16: China – Forecast for POCT Market (Million US$), 2014 – 2018
Figure 6–1: China – Healthcare Spending (Billion US$), 2011 & 2020
Figure 8–1: Roche Diagnostic – China IVD Revenue (Million US$), 2010–2013
Figure 8–2: Roche Diagnostic – Forecast for China IVD Revenue (Million US$), 2014–2018
Figure 8–3: Sysmex Corporation – China IVD Revenue (Million US$), 2010–2013
Figure 8–4: Sysmex Corporation – Forecast for China IVD Revenue (Million US$), 2014–2018
Figure 8–5: Mindray Medical – China IVD Revenue (Million US$), 2010–2013
Figure 8–6: Mindray Medical – Forecast for China IVD Revenue (Million US$), 2014–2018
Figure 8–7: Shanghai Kehua – China IVD Revenue (Million US$), 2010–2013
Figure 8–8: Shanghai Kehua – Forecast for China IVD Revenue (Million US$), 2014–2018
Figure 8–9: Others – China IVD Revenue (Million US$), 2010–2013
Figure 8–10: Others – Forecast for China IVD Revenue (Million US$), 2014–2018
Figure 9–1: Kindstar – Collaboration with Hospitals in China (Number), 2006–2012
2. CHINA IVD MARKET & MARKET SHARE (2007 – 2018)
2.1 China IVD Market (2007 – 2018)
2.2 China IVD Market Share (2007 – 2018)
2.3 China IVD Market Players Share (2010 – 2018)
3. CHINA IVD MARKET BY SEGMENTS (2007 – 2018)
3.1 China Clinical Chemistry Market (2007 – 2018)
3.2 China Immunoassay Market (2007 – 2018)
3.3 China Hematology Market (2007 – 2018)
3.4 China Coagulation Market (2007 – 2018)
3.5 China Microbiology Market (2007 – 2018)
3.6 China Molecular Testing Market (2007 – 2018)
3.7 China Self Monitoring of Blood Glucose (SMBG) Market (2007 – 2018)
3.8 China Point of Care Testing (POCT) Market (2007 – 2018)
4. DEVELOPMENT ENVIRONMENT OF CHINESE IVD INDUSTRY
4.1 State Healthcare Reforms
4.2 State Citizen–Benefiting Policies
4.3 Requirements of Hospital Upgrading
5. PROFILE OF IN–VITRO DIAGNOSTIC REAGENTS REGISTRATION CONTROL
5.1 Regulatory History in China IVD Market
5.2 Regulatory Status in China IVD Market
5.2.1 Blood Screening Reagents — Drug Administration
5.2.2 Varieties of Blood Screening Reagents
5.2.3 Blood Screening Reagent Test
5.2.4 Nucleic Acid Detection Kits for Blood Screening
5.2.5 Radioactive reagents — Drug Administration
5.2.6 Diagnostic Reagents – Medical Devices Management
5.3 Regulatory Trend in China IVD Market
5.3.1 Blood Screening Reagents Belonging
5.3.2 Quality Improvement
5.3.3 Pre–Evaluation of Registration Standards
6. CHINA IVD INDUSTRY DRIVERS
6.1 Government Efforts to Regulate Laboratory testing
6.2 Increasing Number of Private Hospitals & Independent Testing Laboratories
7. CHINA IVD INDUSTRY CHALLENGE
7.1 Lack of Expertise in Advanced Technology in the Local Companies
7.2 Price Pressures Limits the Participation of Multinational IVD Companies in the China IVD Market
7.3 Reimbursement Rates of Different Products are Various in Different Provinces
8. CHINA IVD MARKET – COMPANY WISE SALES ANALYSIS (2010 – 2018)
8.1 Roche Diagnostic – China IVD Sales & Forecast (2010 – 2018)
8.2 Sysmex Corporation – China IVD Sales & Forecast (2010 – 2018)
8.3 Mindray Medical International Limited – China IVD Sales & Forecast (2010 – 2018)
8.4 Shanghai Kehua Bio–Engineering Co. Ltd. – China IVD Sales & Forecast (2010 – 2018)
8.5 Others – China IVD Sales & Forecast (2010 – 2018)
9. PROFILES OF SELECT PRIVATE CLINICAL LABS AND DIAGNOSTIC SERVICES COMPANIES
9.1 Zhejiang Di’an Diagnostics Technology Co., Ltd.
9.1.1 Company Overview
9.1.2 Products and Services Offered by Di’an
9.2 ADICON Clinical Laboratories (Privately held)
9.2.1 Company Overview
9.2.2 Products and Services Offered by ADICON
9.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
9.3.1 Company Overview
9.3.2 Products and Services Offered by Kingmed
9.4 Kindstar Global (Privately held)
9.4.1 Company Overview
9.4.2 Products and Services Offered by Kindstar
9.5 BGI–Shenzhen
9.5.1 Company Overview
9.5.2 BGI’s Innovative Approach
9.6 OriGene Technologies
9.6.1 Company Overview
9.6.2 Products and Services Offered by OriGene
LIST OF FIGURE:
Figure 2–1: China – IVD Market (Million US$), 2007 – 2013
Figure 2–2: China – Forecast for IVD Market (Million US$), 2014 – 2018
Figure 2–3: China – IVD Market Share (Percent), 2007 – 2013
Figure 2–4: China – Forecast for IVD Market Share (Percent), 2014 – 2018
Figure 2–5: China – IVD Market Players Share (Percent), 2010 – 2013
Figure 2–6: China – Forecast for IVD Market Players Share (Percent), 2014 – 2018
Figure 3–1: China – Clinical Chemistry Market (Million US$), 2007 – 2013
Figure 3–2: China – Forecast for Clinical Chemistry Market (Million US$), 2014 – 2018
Figure 3–3: China – Immunoassay Market (Million US$), 2007 – 2013
Figure 3–4: China – Forecast for Immunoassay Market (Million US$), 2014 – 2018
Figure 3–5: China – Hematology Market (Million US$), 2007 – 2013
Figure 3–6: China – Forecast for Hematology Market (Million US$), 2014 – 2018
Figure 3–7: China – Coagulation Market (Million US$), 2007 – 2013
Figure 3–8: China – Forecast for Coagulation Market (Million US$), 2014 – 2018
Figure 3–9: China – Microbiology Market (Million US$), 2007 – 2013
Figure 3–10: China – Forecast for Microbiology Market (Million US$), 2014 – 2018
Figure 3–11: China – Molecular Testing Market (Million US$), 2007 – 2013
Figure 3–12: China – Forecast for Molecular Testing Market (Million US$), 2014 – 2018
Figure 3–13: China – SMBG Market (Million US$), 2007 – 2013
Figure 3–14: China – Forecast for SMBG Market (Million US$), 2014 – 2018
Figure 3–15: China – POCT Market (Million US$), 2007 – 2013
Figure 3–16: China – Forecast for POCT Market (Million US$), 2014 – 2018
Figure 6–1: China – Healthcare Spending (Billion US$), 2011 & 2020
Figure 8–1: Roche Diagnostic – China IVD Revenue (Million US$), 2010–2013
Figure 8–2: Roche Diagnostic – Forecast for China IVD Revenue (Million US$), 2014–2018
Figure 8–3: Sysmex Corporation – China IVD Revenue (Million US$), 2010–2013
Figure 8–4: Sysmex Corporation – Forecast for China IVD Revenue (Million US$), 2014–2018
Figure 8–5: Mindray Medical – China IVD Revenue (Million US$), 2010–2013
Figure 8–6: Mindray Medical – Forecast for China IVD Revenue (Million US$), 2014–2018
Figure 8–7: Shanghai Kehua – China IVD Revenue (Million US$), 2010–2013
Figure 8–8: Shanghai Kehua – Forecast for China IVD Revenue (Million US$), 2014–2018
Figure 8–9: Others – China IVD Revenue (Million US$), 2010–2013
Figure 8–10: Others – Forecast for China IVD Revenue (Million US$), 2014–2018
Figure 9–1: Kindstar – Collaboration with Hospitals in China (Number), 2006–2012
